Please Note: This opportunity has multiple deadlines.
ORS LOI Deadline: March 27, 2015
Agency LOI Deadline: April 9, 2015
ORS Full Proposal Deadline: June 12, 2015
Agency Full Proposal Deadline (by invitation only): June 26, 2015
The Weston Brain Institute recently announced a new international collaborative funding opportunity and has launched a call for Letters of Intent for Biomarkers Across Neurodegenerative Diseases 2 (BAND2). This is a joint initiative with the Alzheimer’s Association (ALZ), the Michael J. Fox Foundation (MJFF) for Parkinson’s Research in the U.S., and Alzheimer’s Research UK (ARUK).
The objective is to stimulate analyses across Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases to increase understanding of pathogenesis similarities and differences. Analyses from this program may support, for example biomarker discovery, assay standardization, genetic profiling, harmonization of existing data set phenotypes, cross-disease analysis of existing genetic data, inclusion of other neurodegenerative diseases related to PD and AD, and imaging development.
Applications are encouraged from research laboratories and teams around the world. Researchers with full-time staff or faculty appointments are encouraged to apply. Post-doctoral fellows are eligible to apply as a principal investigator (PI), but must collaborate with an administrative PI who serves as the director of the laboratory in which the research will be conducted. The administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not be considered.
Up to 2 years.
For details, please consult WBI’s BAND2 information page.
Back to Funding Opportunities